AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23091101 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 477
Study 23091101 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 477
Study 19204028 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylalanine-restricted diet
Number of subjects: 34
Study 19204028 — intervention group
Group type: COMPARATOR
Intervention: Placebo phase
Number of subjects: 34
Study 16970170 — intervention group
Group type: EXPERIMENTAL
Intervention: Huzhangdanshenyin
Number of subjects: 90
Study 16970170 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 90
Study 12517460 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary PTCA
Number of subjects: 7739
Study 12517460 — intervention group
Group type: COMPARATOR
Intervention: Thrombolytic therapy
Number of subjects: 7739
Study 11073141 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefminox 2 g/12 h
Number of subjects: 160
Study 11073141 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole 500 mg/8 h and Gentamicin 80 mg/8 h (M+G)
Number of subjects: 160
Study 8654159 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant IFN-alpha
Number of subjects: 60
Study 8654159 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte IFN-alpha
Number of subjects: 60
Study 8654159 — intervention group
Group type: COMPARATOR
Intervention: IFN-beta
Number of subjects: 60
Study 1529929 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin
Number of subjects: 0
Study 1529929 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin (short-term) with or without long-acting nitrates (chronic)
Number of subjects: 0
Study 3924317 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound scanning
Number of subjects: 51
Study 31127782 — intervention group
Group type: EXPERIMENTAL
Intervention: INT+MNT
Number of subjects: 32
Study 31127782 — intervention group
Group type: EXPERIMENTAL
Intervention: INT-Only
Number of subjects: 32
Study 28374550 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental beliefs about child's ideal portion size
Number of subjects: 217
Study 28374550 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental beliefs about child's maximum tolerated portion size
Number of subjects: 217
Study 28374550 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's self-reported ideal portion size
Number of subjects: 217
Study 28374550 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's self-reported maximum tolerated portion size
Number of subjects: 217
Study 26661467 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation program (28 sessions focused on mobility, balance, and gait exercises)
Number of subjects: 64
Study 26661467 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 64
Study 25143156 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention features including weight-gain tracker, health-related articles, blogs, physical activity and diet goal-setting tools, and local resources.
Number of subjects: 1014
Study 25143156 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention features
Number of subjects: 1014
Study 21939492 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA3 at first repeat biopsy
Number of subjects: 127
Study 21939492 — intervention group
Group type: EXPERIMENTAL
Intervention: %fPSA at second repeat biopsy
Number of subjects: 127
Study 21939492 — intervention group
Group type: EXPERIMENTAL
Intervention: %fPSA at ≥ third repeat biopsy
Number of subjects: 127
Study 21939492 — intervention group
Group type: COMPARATOR
Intervention: tPSA
Number of subjects: 127
Study 21939492 — intervention group
Group type: EXPERIMENTAL
Intervention: PSAV at second and ≥ third repeat biopsy
Number of subjects: 127
Study 20510634 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy delivery during endovenous laser therapy (EVLT), mean energy delivery 89.8 J/cm (range 44.5-158.4 J/cm)
Number of subjects: 232
Study 18555161 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep protocol intervention
Number of subjects: 0
Study 18555161 — intervention group
Group type: COMPARATOR
Intervention: Usual nighttime care (Control)
Number of subjects: 0
Study 15762903 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-based care suggestions delivered to physicians and pharmacists when writing orders or filling prescriptions using computer workstations.
Number of subjects: 706
Study 15762903 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians receiving the intervention (care suggestions).
Number of subjects: 706
Study 15762903 — intervention group
Group type: COMPARATOR
Intervention: Control group (no care suggestions).
Number of subjects: 706
Study 12090977 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 9366
Study 12090977 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 9366
Study 12090977 — intervention group
Group type: COMPARATOR
Intervention: Combination of anastrozole plus tamoxifen
Number of subjects: 9366
Study 10711365 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative autotransfusion
Number of subjects: 700
Study 10711365 — intervention group
Group type: COMPARATOR
Intervention: Control group (homologous blood transfusion)
Number of subjects: 700
Study 10711365 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative autotransfusion vs homologous transfusion
Number of subjects: 700
Study 8954434 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot orthoses
Number of subjects: 0
Study 8954434 — intervention group
Group type: COMPARATOR
Intervention: Control group (no orthoses initially)
Number of subjects: 0
Study 8954434 — intervention group
Group type: COMPARATOR
Intervention: Foot orthoses (after being supplied to control group)
Number of subjects: 0
Study 2011161 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (12.5 or 25 mg per kilogram of body weight)
Number of subjects: 21
Study 2011161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 2011161 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone and Human Chorionic Gonadotropin (2000 IU)
Number of subjects: 21
Study 2011161 — intervention group
Group type: COMPARATOR
Intervention: Placebo (instead of mifepristone and human chorionic gonadotropin)
Number of subjects: 21
Study 7139223 — intervention group
Group type: EXPERIMENTAL
Intervention: Pollen extract
Number of subjects: 20
Study 7139223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31462258 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline brachial-ankle pulse wave velocity (baPWV)
Number of subjects: 2429
Study 31462258 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline baPWV (per SD increment)
Number of subjects: 2429
Study 31462258 — intervention group
Group type: EXPERIMENTAL
Intervention: baPWV assessed as quartiles (≥ 15.9 m/s)
Number of subjects: 2429
Study 31462258 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline baPWV (per SD increment) in participants with impaired fasting glucose (IFG)
Number of subjects: 2429
Study 31462258 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline baPWV (per SD increment) in participants without impaired fasting glucose (IFG)
Number of subjects: 2429
Study 28049268 — intervention group
Group type: COMPARATOR
Intervention: Food Supplementation (FS)
Number of subjects: 355
Study 28049268 — intervention group
Group type: COMPARATOR
Intervention: Food Supplementation and Psychosocial Stimulation (FS+PS)
Number of subjects: 355
Study 28049268 — intervention group
Group type: EXPERIMENTAL
Intervention: Control Group (CG)
Number of subjects: 355
Study 25487904 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric glenoid wear pattern
Number of subjects: 309
Study 25487904 — intervention group
Group type: COMPARATOR
Intervention: Eccentric glenoid wear pattern
Number of subjects: 309
Study 22752296 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice containing PVM/MA copolymer
Number of subjects: 15
Study 22752296 — intervention group
Group type: COMPARATOR
Intervention: Control group (dentifrice without PVM/MA copolymer)
Number of subjects: 15
Study 21367626 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 26
Study 19378223 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg bid
Number of subjects: 254
Study 19378223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 17374691 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat supplementation
Number of subjects: 0
Study 17374691 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain githeri
Number of subjects: 0
Study 17374691 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk supplementation
Number of subjects: 0
Study 17374691 — intervention group
Group type: COMPARATOR
Intervention: Control group (no feedings)
Number of subjects: 0
Study 12608522 — intervention group
Group type: EXPERIMENTAL
Intervention: Intentional weight loss
Number of subjects: 0
Study 12608522 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term weight loss benefits
Number of subjects: 0
Study 12608522 — intervention group
Group type: EXPERIMENTAL
Intervention: Unintentional weight loss
Number of subjects: 0
Study 10487175 — intervention group
Group type: EXPERIMENTAL
Intervention: Video game play
Number of subjects: 212
Study 10487175 — intervention group
Group type: COMPARATOR
Intervention: Leisure activities (reading, physical exercise, puzzles, etc.)
Number of subjects: 212
Study 8945079 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 41
Study 8945079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 1930923 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 bouts of exercise/week for a total of 90 min
Number of subjects: 0
Study 1930923 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 bouts of exercise/week for a total of 210 min
Number of subjects: 0
Study 1930923 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-week exercise in winter
Number of subjects: 0
Study 1930923 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-week exercise in winter
Number of subjects: 0
Study 1930923 — intervention group
Group type: COMPARATOR
Intervention: No added exercise in summer
Number of subjects: 0
Study 6119183 — intervention group
Group type: EXPERIMENTAL
Intervention: BM 12.434
Number of subjects: 0
Study 6119183 — intervention group
Group type: COMPARATOR
Intervention: Metipranolol
Number of subjects: 0
Study 6119183 — intervention group
Group type: COMPARATOR
Intervention: Combination of metipranolol and isosorbide‐5‐mononitrate
Number of subjects: 0
Study 31504419 — intervention group
Group type: EXPERIMENTAL
Intervention: Uninterrupted edoxaban
Number of subjects: 0
Study 31504419 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K antagonists
Number of subjects: 0
Study 28652279 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 199
Study 28652279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study 25561280 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction using a plate
Number of subjects: 492
Study 25561280 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive cannulated screw fixation
Number of subjects: 492
Study 23789885 — intervention group
Group type: EXPERIMENTAL
Intervention: High-MW β-glucan (4 g)
Number of subjects: 15
Study 23789885 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-MW β-glucan (4 g)
Number of subjects: 15
Study 23789885 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 ml β-glucan beverage
Number of subjects: 15
Study 23789885 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 ml β-glucan beverage
Number of subjects: 15
Study 23789885 — intervention group
Group type: EXPERIMENTAL
Intervention: All β-glucan beverages
Number of subjects: 15
Study 22022222 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning style-tailored education materials (information prescriptions)
Number of subjects: 0
Study 22022222 — intervention group
Group type: COMPARATOR
Intervention: Standard care discharge instructions
Number of subjects: 0
Study 19226535 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid tryptophan depletion (RTD) administered within an amino acid drink lacking tryptophan
Number of subjects: 17
Study 19226535 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 19226535 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid tryptophan depletion (RTD)
Number of subjects: 17
Study 16445305 — intervention group
Group type: EXPERIMENTAL
Intervention: Bemiparin plus oral anticoagulants (OAC) for 3 months
Number of subjects: 1000
Study 16445305 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term bemiparin for 3 months
Number of subjects: 1000
Study 16445305 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) plus OAC
Number of subjects: 1000
Study 14727208 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B deoxycholate (1 mg/kg on alternate days for 30 days)
Number of subjects: 153
Study 14727208 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (2 mg/kg per day for 5 days)
Number of subjects: 153
Study 14727208 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B lipid complex (2 mg/kg per day for 5 days)
Number of subjects: 153
Study 14727208 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B deoxycholate
Number of subjects: 153
Study 14727208 — intervention group
Group type: COMPARATOR
Intervention: Liposomal amphotericin B
Number of subjects: 153
Study 14727208 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B lipid complex
Number of subjects: 153
Study 10687755 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol 400 microg
Number of subjects: 863
Study 10687755 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin/Syntometrine
Number of subjects: 863
Study 7861499 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrohydraulic lithotripsy
Number of subjects: 72
Study 7861499 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic lithotripsy
Number of subjects: 72
Study 1783915 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 42
Study 1783915 — intervention group
Group type: COMPARATOR
Intervention: Folic acid (Control)
Number of subjects: 42
Study 7013957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephradine intravenously in the perioperative period (group 1)
Number of subjects: 130
Study 7013957 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole and erythromycin base orally before operation (group 2)
Number of subjects: 130
Study 31169149 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical toothbrush
Number of subjects: 100
Study 31169149 — intervention group
Group type: COMPARATOR
Intervention: Regular toothbrush
Number of subjects: 100
Study 29776326 — intervention group
Group type: EXPERIMENTAL
Intervention: Hum Test (high pitched humming)
Number of subjects: 29
Study 29776326 — intervention group
Group type: EXPERIMENTAL
Intervention: Hum Test (low pitched humming)
Number of subjects: 29
Study 29776326 — intervention group
Group type: COMPARATOR
Intervention: Weber Test
Number of subjects: 29
Study 27253146 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional technique with rotary instruments
Number of subjects: 0
Study 27253146 — intervention group
Group type: COMPARATOR
Intervention: Atraumatic restorative technique (ART)
Number of subjects: 0
Study 23430578 — intervention group
Group type: EXPERIMENTAL
Intervention: Family program and school program
Number of subjects: 0
Study 23430578 — intervention group
Group type: EXPERIMENTAL
Intervention: Family program with high attendance
Number of subjects: 0
Study 23430578 — intervention group
Group type: COMPARATOR
Intervention: School program
Number of subjects: 0
Study 22776409 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency (defined as serum 25(OH)vitamin D <20 ng/mL)
Number of subjects: 499
Study 22776409 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency
Number of subjects: 499
Study 20356486 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day levofloxacin-based triple therapy (amoxicillin, levofloxacin, lansoprazole)
Number of subjects: 300
Study 20356486 — intervention group
Group type: COMPARATOR
Intervention: 7-day standard triple therapy (clarithromycin, amoxicillin, lansoprazole)
Number of subjects: 300
Study 20356486 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 300
Study 16647240 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 15
Study 16647240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 16647240 — intervention group
Group type: COMPARATOR
Intervention: No drug
Number of subjects: 15
Study 15661835 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal exercise with reduced blood flow
Number of subjects: 9
Study 15661835 — intervention group
Group type: COMPARATOR
Intervention: Submaximal exercise without blood flow restriction
Number of subjects: 9
Study 12107601 — intervention group
Group type: EXPERIMENTAL
Intervention: Suplatast tosilate (100 mg three times daily)
Number of subjects: 20
Study 10095821 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 micrograms day‐1 of inhaled budesonide
Number of subjects: 168
Study 10095821 — intervention group
Group type: EXPERIMENTAL
Intervention: 1600 micrograms day‐1 of inhaled budesonide
Number of subjects: 168
Study 10095821 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 micrograms day‐1 of inhaled budesonide plus placebo
Number of subjects: 168
Study 10095821 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg day‐1 of prednisone
Number of subjects: 168
Study 10095821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 7477193 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose nadroparin (4100 anti-factor Xa IU twice daily)
Number of subjects: 312
Study 7477193 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose nadroparin (4100 IU once daily)
Number of subjects: 312
Study 7477193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study 31240513 — intervention group
Group type: COMPARATOR
Intervention: 1% PVP-I (Cohort A)
Number of subjects: 102
Study 31240513 — intervention group
Group type: COMPARATOR
Intervention: 2% PVP-I (Cohort B)
Number of subjects: 102
Study 31240513 — intervention group
Group type: COMPARATOR
Intervention: Vehicle-control (Cohort C)
Number of subjects: 102
Study 27682985 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable electronic vision enhancement system (p‐EVES)
Number of subjects: 82
Study 27682985 — intervention group
Group type: COMPARATOR
Intervention: Optical low vision aids (LVA)
Number of subjects: 82
Study 24484373 — intervention group
Group type: EXPERIMENTAL
Intervention: Online cognitive-behavioral therapy (CBT) for pain management + standard care (n = 17)
Number of subjects: 33
Study 24484373 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition (n = 16)
Number of subjects: 33
Study 24484373 — intervention group
Group type: EXPERIMENTAL
Intervention: Online cognitive-behavioral therapy (CBT) for pain management
Number of subjects: 33
Study 24484373 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter pretreatment sleep duration
Number of subjects: 33
Study 23352524 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in God's role in health
Number of subjects: 0
Study 23352524 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in God's role in health among African American patients
Number of subjects: 0
Study 23352524 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in God's role in health among white patients
Number of subjects: 0
Study 23352524 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in God's role in health among adults
Number of subjects: 0
Study 23352524 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in God's role in health among children
Number of subjects: 0
Study 22100010 — intervention group
Group type: EXPERIMENTAL
Intervention: Managing Oral Hygiene Using Threat Reduction
Number of subjects: 80
Study 22100010 — intervention group
Group type: COMPARATOR
Intervention: Standard mouth care
Number of subjects: 80
Study 19018805 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0
Study 19018805 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine plus tri‐iodothyronine (T(3))
Number of subjects: 0
Study 19018805 — intervention group
Group type: COMPARATOR
Intervention: Psychiatric counselling
Number of subjects: 0
Study 17846333 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 82
Study 17846333 — intervention group
Group type: COMPARATOR
Intervention: Conventional abdominal aortic aneurysm repair (control)
Number of subjects: 82
Study 15565603 — intervention group
Group type: EXPERIMENTAL
Intervention: 180 mug pegylated interferon alpha‐2a once weekly plus daily ribavirin
Number of subjects: 39
Study 11686357 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (3000 IU anti-Xa as an i.v. bolus, followed by 70 IU anti-Xa/Kg every 8 h for 3 days)
Number of subjects: 45
Study 11686357 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (100 IU/kg bolus followed by infusion for 3 days, titrated to maintain aPTT between 70 and 90 s)
Number of subjects: 45
Study 9151268 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite veneer materials
Number of subjects: 18
Study 7874374 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium (0.1 mg/kg i.v.)
Number of subjects: 80
Study 7874374 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipecuronium (0.07 mg/kg i.v.)
Number of subjects: 80
Study 7874374 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium and Pipecuronium (both groups)
Number of subjects: 80
Study 2896868 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched-chain amino acids (12 g L-leucine, 8 g L-isoleucine, 6.4 g L-valine)
Number of subjects: 22
Study 2896868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 29080948 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS
Number of subjects: 289
Study 29080948 — intervention group
Group type: COMPARATOR
Intervention: CRAS
Number of subjects: 289
Study 27459236 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty screening intervention followed by usual care from a general practitioner
Number of subjects: 3092